Overview
Few lipids in preventive cardiology are as strictly genetically programmed as Lipoprotein(a) [Lp(a)]. While LDL cholesterol responds strongly to diet and weight, more than 90 percent of blood Lp(a) concentration is fixed at birth by Kringle repeat length and tag SNPs inside the LPA gene.
Roughly one in five adults carries elevated Lp(a) without knowing it, because standard lipid panels do not report it unless ordered specifically—yet cardiovascular genetics identifies Lp(a) as a potent independent driver of atherosclerosis and calcific aortic valve stenosis.
6q25.3-q26 (Chromosome 6)
Metabolism & Cardiovascular
Apolipoprotein(a) Structural Gene
Genetically fixed Lp(a) & heart risk
Function of LPA
Structurally, Lp(a) resembles an LDL cholesterol particle carrying an extra sticky coiled protein ribbon—apolipoprotein(a)—whose structure mimics plasminogen, promoting oxidized phospholipid trapping in arterial plaques and interfering gently with clot lysis.
Key Aspects:
🧬 Kringle Repeats & Tag SNPs
Fewer Kringle IV type 2 repeats let the liver secrete Apo(a) much faster, skyrocketing plasma Lp(a). Variants rs10455872 (G) and rs3798220 (C) reliably flag small, high-output alleles.
❤️ Aggressive Overall Risk Control
Even though diet and statins barely lower Lp(a) itself, lowering total ApoB/LDL cholesterol, blood pressure, and blood sugar drastically shrinks lifetime plaque risk.
🧬 Genetic Variants (SNPs)
Two landmark NEJM-validated SNPs account for a major share of severe genetic Lp(a) elevation:
6:160589086
G carriers typically exhibit 3- to 5-fold higher median Lp(a) blood concentrations and ~1.5x higher coronary disease odds.
~7-8% (Europe)
6:160540105
Protease-like domain substitution tightly tagging elevated small-isoform Lp(a) particles and earlier myocardial infarction onset.
~2% (Europe)
Practical Significance
✅ Strategies & Guidance
- Order a Blood Lp(a) Test: Preferably in nmol/L (risk climbs above 75–125 nmol/L / 30–50 mg/dL); DNA SNPs never replace direct blood measurement.
- Drive Down ApoB & LDL-C: Because Lp(a) cannot yet be lowered easily with diet, optimizing overall ApoB via Mediterranean nutrition and clinician-guided LDL lowering (e.g., PCSK9/statins) shrinks cumulative arterial hazard.
- Optimize Vascular Hygiene: Zero smoking, tight blood pressure control (<120/80 mmHg), regular aerobic exercise, and blood-sugar stewardship.
⚠️ Clinical Notes & Risks
- Silent Premature Plaque: Elevated Lp(a) explains many unexpected early heart attacks despite apparently ‘normal’ standard LDL numbers.
- Calcific Aortic Valve Disease: Carried oxidized phospholipids accelerate aortic valve stiffening—echocardiographic follow-up matters when levels run high.
- Familial Screening: When elevated Lp(a) (>50 mg/dL) is found, first-degree relatives carry a 50% chance of sharing it.
📚 Data Sources
- OMIM: #152200 (Lipoprotein(a) / Apolipoprotein(a))
- dbSNP: rs10455872, rs3798220
- ESC/EAS Dyslipidaemia Guidelines: Universal Adult Lp(a) Testing Recommendation
- NEJM (Clarke et al.): Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
Last Update: November 2026
Related Research Guides for LPA
Related Genes in Metabolism
CYP2D6
CYP2D6 is one of the most important enzymes for drug metabolism (e.g., antidepressants, beta-blockers, painkillers)....
FABP2
FABP2 transports long-chain dietary fatty acids inside small-intestine enterocytes. The Ala54Thr variant (rs1799883) doubles fatty-acid binding…
FADS1
FADS1 encodes Delta-5 Desaturase, a key enzyme for synthesizing long-chain Omega-3 and Omega-6 fatty acids....